Compliance and Enforcement Regulatory Activities Clinical Investigators - Disqualification Proceedings Return to Introductory Page
Name Center Status Date of status Date NIDPOE Issued Date NOOH Issued Link to NIDPOE Letter Link to NOOH Letter Gelfand, Michael C., MD
Burea
Not Disqualified
09/11/1981
Lippmann, Maurice, MD
Burea
Reinstated – Adequate Assurances1
11/05/1984
Steen, Stephen N., MD
Burea
Not Disqualified – Adequate Assurances1
09/05/1985
Mok, Martin S., MD
Burea
Not Disqualified – Adequate Assurances1
03/23/1983
Daley, Patrick J., MD
CBER
Disqualified
03/14/2008
06/23/2003
02/04/2004
PDF Text
PDF Text Kim, Christopher M., MD
CBER
Not Disqualified
10/20/1993
03/23/1993
Kornblith, Paul, MD
CBER
Disqualified
11/25/1991
05/29/1991
Lasala, Gabriel Perez, MD
CBER
Restricted
07/16/2013
02/16/2012
PDF Text
Law, Peter K., PhD
CBER
Disqualified
10/23/2006
06/30/2000
11/01/2002
PDF
PDF Text Lieberman, Ellin, MD
CBER
Disqualified
10/12/1993
02/23/1993
Lofgren, David Nils, MD
CBER
Disqualified
04/28/2008
11/09/2007
PDF Text
Marcus, Eugenia, MD
CBER
Disqualified
10/03/2004
04/22/2004
PDF Text
McCracken, Elbert, MD
CBER
Disqualified
05/03/1977
07/12/1976
10/27/1976
McGee, J Michael, MD
CBER
Disqualified
01/08/2009
06/21/2001
05/21/2002
PDF
PDF Text Mittelman, Abraham, MD
CBER
Restrictions Removed
12/09/1995
08/11/1993
12/27/1993
Najarian, John S., MD
CBER
Restrictions Removed
11/17/1998
02/23/1993
12/30/1993
Niederman, Alan, MD
CBER
Restrictions Removed
07/25/2014
11/01/2010
PDF Text
Page, Roy C., MD
CBER
Disqualified
04/04/2003
04/06/2000
01/08/2002
PDF
PDF Text Raper, Steven, MD
CBER
Restricted
02/10/2005
Roberts, William S., MD
CBER
Disqualified
07/18/1991
05/14/1991
Richards, Jon, MD
CBER
Restrictions Removed
05/12/2016
08/28/2012
PDF Text
Runels, Jr., Charles E., MD
CBER
Disqualified
08/06/2009
08/27/2008
02/13/2009
PDF Text
PDF Slazinski, Leonard, MD
CBER
Disqualified
08/28/1991
05/14/1991
Spencer, Wayne E., MD
CBER
Disqualified
05/09/2011
04/20/2011
PDF Text
Tewari, Anand, MD
CBER
Disqualified
11/18/1993
03/23/1995
Vriesendorp, Huibert M., MD, PhD
CBER
Disqualified
12/31/2001
11/19/1996
09/19/1997
Chang, Alfred E., MD
CBER
Disqualified
04/07/2010
11/06/2002
10/09/2003
PDF Text
PDF Text Bigg, Daniel, MD
CBER
Disqualified
05/18/2007
01/24/2007
PDF Text
Wilson, James M., MD, PhD
CBER
Restricted
02/09/2005
11/30/2000
02/08/2002
PDF
PDF Text Batshaw, Mark L., MD
CBER
Restrictions Removed
10/01/2007
Berger, Michael Dean, MD
CBER
Disqualified
06/20/2014
09/26/2011
12/18/2012
PDF
PDF Ziering, William H., MD
CDER
Disqualified
05/20/2008
11/06/1998
08/16/1999
PDF
PDF Text Allman, Richard M., MD
CDER
Restrictions Removed
09/01/2002
07/10/1998
06/28/1999
PDF Text
PDF Text Anderson, Roger D., MD
CDER
Disqualified
01/10/2005
09/13/2000
PDF Text
Aronow, Wilbert S., MD
CDER
Totally Restricted
10/28/1982
Aroonsakul, Chaovanee, MD
CDER
Disqualified
10/16/1991
11/24/1989
Balin, Howard, MD
CDER
Disqualified
03/19/1975
Baratta, Vincent J, MD
CDER
Disqualified
11/13/1985
Bazo, Albert J., MD
CDER
Restricted
11/04/1981
11/04/1981
Bender, Sheldon R., MD
CDER
Disqualified
02/17/1969
Berger, Daniel S., MD
CDER
Restrictions Removed
09/10/2014
11/27/2009
PDF
Blunck, Jr., Carl E., MD
CDER
Disqualified
07/07/1979
Borison, Richard L., MD
CDER
Disqualified
11/10/1998
Bowling, Chetwynd E., MD
CDER
Disqualified
11/13/1980
Boyles, Paul W., MD
CDER
Disqualified
04/13/1995
07/10/1990
04/26/1991
Browne, Brian, MD
CDER
Restrictions Removed
12/23/1997
12/23/1992
Bruschi, Walter C., MD
CDER
Totally Restricted
06/28/1983
Bushnell, Walter J., MD
CDER
Disqualified
09/16/1988
03/03/1988
Caldwell, Jacques R., MD
CDER
Restricted
05/11/2006
06/10/2004
03/08/2006
PDF Text
PDF Text Carter, Charles, MD
CDER
Reinstated
07/29/1969
Prev
|
Next
|
[1]
|
2
|
3
|
4
|
5
|
First
|
Last
|
All
1. Under regulations in effect until 1987, investigators who met the standard for disqualification (repeated or deliberate failure to comply with applicable requirements) could potentially avoid disqualification and continue to be eligible to receive investigational products if they could provide FDA with adequate assurances of future compliance with requirements applicable to the use of investigational drugs and biologics. The provisions for adequate assurances are no longer in the regulations.